Cell and gene therapies are transforming modern medicine by enabling treatment of genetic, rare, and previously untreatable diseases. However, advancing these therapies involves complex, data-heavy research, highly personalized manufacturing workflows, and strict quality requirements. For R&D organizations, success now depends not only on scientific expertise but also on the ability to digitize, automate, and intelligently manage laboratory operations. Artificial intelligence has become a key driver of this transformation, converting vast amounts of scientific data into predictive insights that improve decision-making, optimize processes, and speed discovery. This white paper describes how LabVantage’s AI-enabled digital ecosystem supports CGT laboratories.

Join for free to read